Bio

Daniel Schnurman is a Managing Director in Cowen’s Mergers & Acquisitions Group. Mr. Schnurman provides strategic and financing advice to public and private companies, and private equity firms who are active in the Specialty Pharma, Generics and Pharmaceutical Outsourcing industries. Mr. Schnurman also advises medical cannabis clients as well as those interested in investing in, or expanding into, the global Medical Cannabis industry. Mr. Schnurman has been a banker for over 20 years and has extensive experience in mergers and acquisitions, cross border transactions, capital raising, take private transactions and restructurings. Before Cowen, he worked with PricewaterhouseCoopers where he was the Head of Healthcare Corporate Finance, focused on originating and executing strategic transactions in the Life Sciences sector. Prior to that, he was a Managing Director on the Health Care Investment Banking team at UBS and led coverage of UBS’s Specialty and Generics Pharmaceuticals investment banking practice in the Americas. Mr. Schnurman holds a Bachelor of Arts (Pre-Med) from Rice University, a J.D. from Washington University School of Law and an MBA from the Wharton School.